BOSTON (Reuters) - Vertex Pharmaceuticals Inc said on Tuesday it will discontinue development of an experimental drug to treat hepatitis C after it failed to show sufficient efficacy.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment